FDA Drug Application (087398) for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number087398
Product Number001
FormTABLET;ORAL
Dosage25MG;25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient SPIRONOLACTONE5


Back to FDA Applications sponsored by WATSON LABS